arabinose has been researched along with Pseudomonas Infections in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Cervoni, M; Imperi, F; Lo Sciuto, A; Mancone, C; Stefanelli, R | 1 |
Brannon, MK; Gutu, AD; Haugen, E; Høiby, N; Jacobs, MA; Johansen, HK; Kaul, RK; Moskowitz, SM; Sgambati, N; Strasbourger, P | 1 |
Adams, KN; Burns, JL; Emerson, JC; Ernst, RK; Harvey, MD; Kraig, GM; Miller, SI; Moskowitz, SM; Ramsey, B; Speert, DP | 1 |
Burns, JL; Ernst, RK; Guo, L; Hackett, M; Lim, KB; Miller, SI; Yi, EC | 1 |
4 other study(ies) available for arabinose and Pseudomonas Infections
Article | Year |
---|---|
Effect of lipid A aminoarabinosylation on Pseudomonas aeruginosa colistin resistance and fitness.
Topics: Animals; Anti-Bacterial Agents; Arabinose; Biofilms; Colistin; Disk Diffusion Antimicrobial Tests; Drug Resistance, Multiple, Bacterial; Humans; Lipid A; Moths; Pseudomonas aeruginosa; Pseudomonas Infections | 2020 |
Polymyxin resistance of Pseudomonas aeruginosa phoQ mutants is dependent on additional two-component regulatory systems.
Topics: Anti-Bacterial Agents; Arabinose; Bacterial Proteins; Cystic Fibrosis; DNA Transposable Elements; Drug Resistance, Bacterial; Gene Deletion; Gene Expression Regulation, Bacterial; Genes, Regulator; Genetic Complementation Test; Genetic Loci; Humans; Lipid A; Mutation; Plasmids; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections | 2013 |
Unique lipid a modifications in Pseudomonas aeruginosa isolated from the airways of patients with cystic fibrosis.
Topics: Arabinose; Child; Child, Preschool; Chronic Disease; Cystic Fibrosis; Decanoic Acids; Humans; Infant; Lipid A; Lung Diseases; Palmitates; Prevalence; Pseudomonas aeruginosa; Pseudomonas Infections | 2007 |
Specific lipopolysaccharide found in cystic fibrosis airway Pseudomonas aeruginosa.
Topics: Acylation; Antimicrobial Cationic Peptides; Arabinose; Bacterial Proteins; Cells, Cultured; Cystic Fibrosis; Drug Resistance, Microbial; Humans; Infant; Interleukin-8; Lipid A; Lipopolysaccharides; Magnesium; Mutation; Palmitates; Peptides; Polymyxins; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory System; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Virulence | 1999 |